{
}
Navann Ty Dietschi presented at the BNP Paribas 2nd Annual Animal Health Day on May 22, 2025, discussing developments in the animal health sector, including insights on Zoetis Inc. The event highlighted the company's role and advancements in the industry.
BNP Paribas Exane has raised its price target on Zoetis Inc. to $226 from $219 while maintaining an outperform rating. Zoetis specializes in animal health products, with net sales primarily from companion animals (67.8%) and livestock (31.3%), and operates 22 production sites globally, with the U.S. contributing 54.8% of sales.
UBS has lowered its price target for Zoetis (ZTS) from $189 to $170, maintaining a "Neutral" rating, reflecting a 10.05% decrease. Analysts project an average target price of $197.49, indicating a potential upside of 29.50% from the current price of $152.51, with a consensus recommendation of "Outperform."
Zoetis Inc. (NYSE:ZTS) reported a quarterly EPS of $1.40, surpassing estimates, with revenue of $2.32 billion. The company announced a quarterly dividend of $0.50 per share, yielding 1.33%, and has a market cap of $67 billion. Analysts maintain a "Buy" rating, with a consensus price target of $214.40.
Companies are experiencing heightened uncertainty reminiscent of the early COVID-19 pandemic, driven by President Trump's unpredictable tariff policies, which complicate future planning. Analysts at Morgan Stanley predict the benchmark will trade between 5,000 and 5,500, urging investors to seek high-quality stocks in less risky sectors, highlighting names like Ecolab, Halozyme, and Apple. The Federal Reserve's cautious stance on interest rates adds to the economic murkiness, as it awaits clarity on the tariffs' impact.
Morgan Stanley lowered its price target on Zoetis to $238, maintaining an "overweight" rating, while Piper Sandler raised theirs to $205. Various analysts have given mixed ratings, with an average target price of $215.90 and a majority rating the stock as a buy. Insider trading activity included the sale of 326 shares by EVP Roxanne Lagano, and Banco Santander increased its stake by 9.8%. Zoetis reported a quarterly EPS of $1.40, exceeding estimates, and announced a quarterly dividend of $0.50 per share.
BNP Paribas Exane has revised its price target for Zoetis Inc. to $219 from $232 while maintaining an outperform rating. Zoetis specializes in animal health products, with net sales primarily from companion animals (67.8%) and livestock (31.3%), and operates 22 production sites globally, with the U.S. contributing 54.8% of sales.
UBS has adjusted its price target on Zoetis Inc. to $189 from $193 while maintaining a neutral rating. The company focuses on animal health products, with net sales primarily from pets (64.4%) and livestock (34.5%), and operates 29 production sites globally, with the U.S. contributing 53.4% of sales.
UBS has adjusted its price target for Zoetis Inc. to $193 from $196 while maintaining a neutral rating. The company focuses on animal health products, with net sales primarily from pets (64.4%) and livestock (34.5%), and operates 29 production sites globally, with the U.S. contributing 53.4% of sales.
UBS has initiated coverage of Zoetis (ZTS) with a Neutral rating and a price target of $196. The firm highlights the company's strong position due to a multi-year innovation cycle, projecting a 6% revenue CAGR and 7% EBITDA CAGR from 2025-2030, while noting a balanced risk/reward profile amid concerns over slowing growth.
Zoetis Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Zoetis Inc. Presents Insights at BNP Paribas Animal Health Day 2025
19:37 23.05.2025
bnp paribas exane raises zoetis price target to 226 maintains outperform rating
20:46 09.05.2025
ubs lowers zoetis price target to 170 maintains neutral rating
17:38 07.05.2025
zoetis reports strong earnings and announces quarterly dividend increase
12:05 25.04.2025
companies face heightened uncertainty amid tariffs and economic challenges
United States Dollar
Chinese Yuan
Zoetis Inc.
Arista Networks Inc
Apple Inc.
Ecolab Inc.
CHN
USA
Nile Wilson
Donald Trump
Jerome Powell
Show more
12:34 21.04.2025
zoetis stock ratings updated as analysts adjust price targets and holdings
11:15 09.03.2025
bnp paribas exane lowers zoetis price target to 219 maintains outperform rating
14:39 27.02.2025
ubs lowers zoetis price target to 189 maintains neutral rating
15:09 14.02.2025
ubs lowers zoetis price target to 193 maintains neutral rating
14:56 10.02.2025
UBS Initiates Coverage of Zoetis with Neutral Rating and Price Target
15:43 10.12.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Industry Trends
AI Innovations
Venture Capital Investments
Retail and Consumer Goods
Emerging Startups
Funding Rounds & Investments
Fintech Startups
AI Applications
Stock Market Updates
Economic Indicators
Government Economic Policies
Global Trade Developments
Cryptocurrency Trends
Financial Scams and Security
Energy Sector Developments
Private Equity Deals
Consumer Protection Regulations
Macro-economic Trends
Countries:
Companies:
Google Inc.
Alphabet Inc.
Nvidia Corporation
Google LLC
Battery Ventures X LP
Khosla Ventures LLC
Poalim Equity Ltd.
Oxyzo Financial Services Ltd.
BOCHK Asset Management Ltd.
HSBC Saudi Arabia
Marvell Technology Inc.
Nippon Steel Corporation
Sony Corporation
Ford Motor Company
Mitsubishi Motors Corporation
Eternal Capital LP
Maximus International Ltd.
Ather Energy Ltd.
Ola Electric Mobility B.V.
Super Micro Computer Inc.
Currencies:
United States Dollar
Indian Rupee
Offshore Chinese Yuan
Chinese Yuan
Hong Kong Dollar
Egyptian Pound
Saudi Riyal
Indonesian Rupiah
People: